HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II clinical trial with Praneem polyherbal tablets for assessment of their efficacy in symptomatic women with abnormal vaginal discharge (an ICMR task force study).

Abstract
Abnormal vaginal discharge syndrome (AVDS) is a commonly observed gynaecological complaint for which women seek medical attention. The present study was conducted in six Indian Council of Medical Research centres with Praneem polyherbal tablets (PPT), to determine their efficacy in the treatment of symptomatic women with AVDS. Data are given on 141 subjects investigated. In total, 137 women (97%) reported complete (n=62, 44%) and partial (n=75, 53%) relief from symptoms after use of PPT for seven consecutive days. On speculum examination, 71 (74%) women were confirmed to be cured of AVDS. Microbiological tests could only be conducted microscopically for Trichomonas vaginalis, Candida albicans and bacterial vaginosis. It was observed that all women with T. vaginalis had this infection cured by PPT, and the cure rate was 77% for C. albicans and 68% for bacterial vaginosis. Seventy-eight women (55%) reported a transient burning sensation, mostly on the first 2 d of intake of PPT; however, they continued to use the tablets for the prescribed 7 d. This study lays the basis for an extended Phase II/III clinical trial, preferably randomized and comparing a larger number of women to confirm the safety and efficacy of PPT.
AuthorsR S Sharma, A K Mathur, N Chandhiok, S Datey, N C Saxena, S Gopalan, S Sharma, S Mittal, R Sehgal, B K Sumandal, A Chanda, V Salvi, N Mutalik, K J Coyaji, A Gibsson, K Hazari, S Kalgutkar, G P Talwar
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) Vol. 103 Issue 2 Pg. 167-72 (Feb 2009) ISSN: 1878-3503 [Electronic] England
PMID18990416 (Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifungal Agents
  • Antiprotozoal Agents
  • Plant Extracts
  • Praneem
  • Tablets
  • Quinine
Topics
  • Administration, Intravaginal
  • Adult
  • Advisory Committees
  • Animals
  • Antifungal Agents (adverse effects, therapeutic use)
  • Antiprotozoal Agents (adverse effects, therapeutic use)
  • Candidiasis (drug therapy, microbiology)
  • Female
  • Humans
  • Middle Aged
  • Phytotherapy (adverse effects)
  • Plant Extracts (adverse effects, therapeutic use)
  • Quinine (adverse effects, therapeutic use)
  • Tablets
  • Treatment Outcome
  • Trichomonas Vaginitis (drug therapy)
  • Vaginal Discharge (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: